Clinical Trials Directory

Trials / Completed

CompletedNCT03789565

Hepcidin Levels in Periodontal Health and Disease

Gingival Crevicular Fluid and Serum Levels of Hepcidin, IL-6 and IL-10 in Periodontal Health and Disease

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Bulent Ecevit University · Academic / Other
Sex
All
Age
32 Years – 52 Years
Healthy volunteers

Summary

Periodontal disease refers to inflammatory disease of the periodontium caused by the host and/or pathogenic microorganisms. Anti-inflammatory and pro-inflammatory cytokines play a role in the periodontal inflammation process. The aim of this study was to evaluate the levels of hepcidin, interleukin (IL)-6, and IL-10 levels in gingival crevicular fluid (GCF) and in serum samples obtained from individuals with periodontal inflammation.

Detailed description

The study included 90 individuals, who were divided into three groups: periodontally healthy (PH) (n=30); gingivitis (G) (n=30); and chronic periodontitis (CP) (n=30). GCF and serum samples were obtained from each individual, and samples were evaluated using ELISA. Statistical evaluation of the data was performed using the SPSS packet data program.

Conditions

Interventions

TypeNameDescription
OTHERBiomarker testDiagnostic biomarker study

Timeline

Start date
2017-03-15
Primary completion
2018-01-20
Completion
2018-02-15
First posted
2018-12-28
Last updated
2019-10-04

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03789565. Inclusion in this directory is not an endorsement.